New combo therapy shows promise for deadly lung disease Flare-Ups
NCT ID NCT03286556
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study tested a treatment for people with idiopathic pulmonary fibrosis (IPF) who experience sudden, severe worsening of their condition. The treatment combined plasma exchange, rituximab, and intravenous immunoglobulin to target harmful antibodies. The goal was to improve survival during these dangerous episodes. The study included 82 adults aged 40-85 with confirmed IPF and recent worsening symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Houston, Texas, 77030, United States
-
Dan Dilling
Chicago, Illinois, 60611, United States
-
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
-
Thomas Jefferson University Medical Center
Philadelphia, Pennsylvania, 19107, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
University of Utah Medical Center
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.